Active ingredient and composition:
Each hard gelatin capsule contains:
Cefadroxil USP equivalent to Anhydrous Cefadroxil 500 mg.
Excipients: lactose anhydrous, croscarmellose sodium, magnesium stearate.
Treatment of patients with infection caused by susceptible strains of the designated organisms in the following diseases: urinary tract infections caused by E. Coli, P. Mirabilis and Klebsiella species, skin and skin structure infections caused by staphylococci and/or streptococci, pharyngitis and/or tonsillitis caused by Streptococcus pyogenes (Group A beta-hemolytic streptococci). Cefadroxil monohydrate is generally effective in the eradication of streptococci from the oropharynx. To reduce the development of drug-resistant bacteria and maintain the effectiveness of Cefadroxizen-500 capsules and other antibacterial drugs, Cefadroxizen Capsules should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria.
CEFADROXIZEN-500 is contraindicated in patients with known allergy to the cephalosporin group of antibiotics.
CEFADROXIZEN-500 Capsules is available as 500 mg Cefadroxil capsules in blister packs of 10´s (100 capsules). Possibility to adapt packing and quantities to customer needs.
For oral administration.